Transform Evidence into Compelling Narratives
Strong data is the foundation—but how you communicate that data can make or break your market access success. At Kintiga, we help you turn technical evidence into compelling, tailored value messages that resonate with diverse stakeholders across Europe. From payers and HTA bodies to clinicians and patient advocates, our strategic communication experts ensure your product’s value story is relevant, persuasive, and scientifically sound.
We provide:
- Stakeholder engagement planning and execution
- Stakeholder mapping & engagement
- Core Value Dossiers (CVDs) and Global Value Dossiers (GVDs)
- Payer-facing materials and objection-handling tools
- Advisory board moderation and insight generation
- Strategic message development aligned with evidence
With a strong narrative and stakeholder-focused approach, we help your product not just gain access—but gain support.
Our services
We provide expertise in:
Innovative therapies deserve messaging that is just as powerful. We ensure your product is supported by a clear, compelling narrative and consistent evidence that fully reflects its value.
By combining insights from market access, HEOR, strategic pricing, policy and public affairs, we ensure your asset’s value is captured in a cohesive, persuasive dossier.
We support with:
- Evidence generation including systematic literature reviews, RWE projects (e.g.OHDSI/OMOB) and HEOR analyses
- Scientific abstract, poster and manuscript development for peer-reviewed journals
- Promising Innovative Medicine (PIM) applications
- Early Access to Medicines Scheme (EAMS) applications
- Innovative Licensing and Access pathway (ILAP) applications
- Global value dossier development
Navigating stakeholder dynamics is a laborious process without the right support. We help you engage early in the process with HTA bodies, payers, regulators, KOLs, PAGs and other influential stakeholders, ensuring their perspectives shape every aspect of your approach towards sustained patient access.
We support with:
- Advisory boards
- Delphi panels
- Expert elicitation research
- Scientific stakeholder management, including Medical Science Liaison (MSL) service
- Building and maintaining relationships with external stakeholders
